Showing results (161-170 of 423) with videos related to

Sort By:
Pageof 43
Heart, Lung & Circulation|November 6, 2022
Oral Anticoagulant Use in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Review of the Evidence With Recommendations for Australian Clinical PracticeChristopher Hammett, Sunil V Badve, Peter G Kerr, et al.
Endocrinology, Diabetes & Metabolism|July 19, 2021
Canagliflozin, serum magnesium and cardiovascular outcomes-Analysis from the CANVAS ProgramKatherine M Wang, JingWei Li, Vivek Bhalla, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 12, 2021
Rationale, design, demographics and baseline characteristics of the randomized, controlled, Phase 2b SAPPHIRE study of verinurad plus allopurinol in patients with chronic kidney disease and hyperuricaemiaHiddo J L Heerspink, Austin G Stack, Robert Terkeltaub, et al.
Cardiovascular Diabetology|September 23, 2022
Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failureSok Cin Tye, Niels Jongs, Steven G Coca, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 8, 2025
Systemic Inflammation and the Risks of Adverse Kidney Outcomes in Adults With Atherosclerotic Cardiovascular DiseaseFaizan Mazhar, Edouard L Fu, Anne-Laure Faucon, et al.
Nephrology (Carlton, Vic.)|July 20, 2025
Changes in Dialysis Practice Patterns in Australia and New Zealand During the COVID-19 Pandemic PeriodDaniela Potter, Kevan R Polkinghorne, Annie Conway, et al.
Kidney International|November 26, 2016
Management of patients with diabetes and CKD: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies ConferenceVlado Perkovic, Rajiv Agarwal, Paola Fioretto, et al.
BMJ (Clinical Research Ed.)|November 9, 2016
Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: systematic review and meta-analysisLouisa Sukkar, Daqing Hong, Muh Geot Wong, et al.
Diabetes Care|October 29, 2017
Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ONMin Jun, Toshiaki Ohkuma, Sophia Zoungas, et al.
Diabetes & Vascular Disease Research|July 31, 2015
Dipeptidyl peptidase-4 inhibition with linagliptin and effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: Rationale and design of the MARLINA-T2D™ trialPer-Henrik Groop, Mark E Cooper, Vlado Perkovic, et al.
Pageof 43